# A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients

> **NCT05552339** · — · COMPLETED · sponsor: **Bayer** · enrollment: 348 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Chronic Kidney Disease

## Interventions

- **DRUG:** Finerenone (Kerendia, BAY94-8862)
- **DRUG:** Type 2 DM drugs

## Key facts

- **NCT ID:** NCT05552339
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-18
- **Primary completion:** 2025-11-18
- **Final completion:** 2025-11-18
- **Target enrollment:** 348 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05552339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05552339, "A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05552339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*